Calidi Biotherapeutics Inc（CLDI）價格預測CLDICalidi Biotherapeutics Inc

Alphio's CLDI stock price prediction model matches the current Calidi Biotherapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.30 (-1.14%). The 1-week path is $1.36 (+3.34%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Calidi Biotherapeutics Inc is currently not a good buy due to its significant financial losses and low price performance. The stock is trading at $1.32, down 93.01% year-to-date, and has an RSI of 38.409, indicating it is nearing oversold territory but not yet a strong buy signal. The company has reported consistent net losses, with a net income of -$4,416,000 in Q1 2026 and -$4,160,000 in Q2 2026, raising concerns about its financial stability. Additionally, the proposed 1-for-16 reverse stock split may not instill confidence among investors, as the stock is currently trading at a low price and has seen a 95% decline over the past year, suggesting a lack of market confidence in its recovery prospects.

Calidi Biotherapeutics Inc (CLDI) last closed at $1.32, gaining +1.54%. These facts feed the 1-day and 1-week CLDI price prediction above.